Highlights: India's CDSCO grants approval for Afrezza, an inhalable insulin spray, offering a needle-free alternati
Vous n'êtes pas connecté
Afrezza, a needle-free inhalable insulin spray, has been approved in India, offering a convenient and painless solution for managing diabetes.
Highlights: India's CDSCO grants approval for Afrezza, an inhalable insulin spray, offering a needle-free alternati
FRIDAY, March 21, 2025 -- For individuals with type 1 diabetes, low-glucose alerts improve the time below range for drivers and reduce the incidence...
FRIDAY, March 21, 2025 -- For individuals with type 1 diabetes, low-glucose alerts improve the time below range for drivers and reduce the incidence...
JAKARTA: As Eid al-Fitr draws near, pet hotels across Jakarta are experiencing a surge in demand, offering a safe and convenient solution for pet...
Capsaicin in chili peppers may aid in managing gestational diabetes by improving insulin sensitivity and reducing inflammation, supporting better...
New Zealand Prime Minister Christopher Luxon paid a four-day visit to India from 16 to 20 March 2025, during which a series of agreements were...
The good steady run of reasonable pricing across export log sales over the last five months is now facing some head winds as a number of factors line...
Eli Lilly plans to turn India into a growth market by addressing its diabetes and obesity challenges with its new treatment, Mounjaro. CEO David Ricks...
Eli Lilly plans to turn India into a growth market by addressing its diabetes and obesity challenges with its new treatment, Mounjaro. CEO David Ricks...
The Bihar Board has declared the 2025 Class 12 results, with an overall pass percentage of 86.50%. The pass percentages for individual streams are...